EQUITY COMMITMENT AND INVESTMENT AGREEMENT dated as of March 8, 2021 by and among ANI Pharmaceuticals, Inc. and Ampersand 2020 Limited PartnershipEquity Commitment and Investment Agreement • March 9th, 2021 • Ani Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 9th, 2021 Company Industry JurisdictionThis EQUITY COMMITMENT AND INVESTMENT AGREEMENT, dated as of March 8, 2021 (this “Agreement”), is by and between ANI Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Ampersand 2020 Limited Partnership, a Delaware limited partnership (the “Purchaser”).
EQUITY COMMITMENT AND INVESTMENT AGREEMENT dated as of April 14, 2019 by and among Catalent, Inc., Green Equity Investors VII, L.P. and Green Equity Investors Side VII, L.P.Equity Commitment and Investment Agreement • April 17th, 2019 • Catalent, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 17th, 2019 Company Industry JurisdictionEQUITY COMMITMENT AND INVESTMENT AGREEMENT, dated as of April 14, 2019 (this “Agreement”), by and among Catalent, Inc., a Delaware corporation (the “Company”), and each of Green Equity Investors VII, L.P., a Delaware limited partnership (“Fund VII”), and Green Equity Investors Side VII, L.P., a Delaware limited partnership (“Fund Side VII” and, together with Fund VII, the “Purchaser”). The obligations of the Purchaser set forth in this Agreement shall be several and not joint among Fund VII and Fund Side VII and apportioned in percentages of 45.83720% and 54.16280%, respectively.